ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Construction of Metabolic Molecular Classification and Immune Characteristics for the Prognosis Prediction of Ovarian Cancer

Wang, Kexin; He, Hui; Feng, Xue*哈尔滨医科大学; 1
Journal of Immunology Research2022-6-25DOI: 10.1155/2022/2359349
2被引6阅读
引用收藏
分享

摘要

Background. Ovarian cancer (OC) is a malignant tumor that seriously threatens women's health. Molecular classification based on metabolic genes can reflect the deeper characteristics of ovarian cancer and provide support for prognostic evaluation and the guidance of individualized treatment. Method. The metabolic subtypes were determined by consensus clustering and CDF. We used the ssGSEA method to calculate the IFN gamma score of each patient. The CIBERSORT method was used to evaluate the score distribution and differential expression of 22 immune cells, and LDA was applied to establish a subtype classification feature index. The Kaplan-Meier and ROC curves were generated to validate the prognostic performance of metabolic subtypes in different cohorts. WGCNA was used to screen the coexpression modules associated with metabolic genes. Results. We obtained three metabolic subtypes (MC1, MC2, and MC3). MC2 had the best prognosis, and MC1 and MC3 had poor prognoses. Consistently, MC2 subtype had higher T cell lytic activity and lower angiogenesis, IFN gamma, T cell dysfunction, and rejection scores. TIDE analysis showed that MC2 patients were more likely to benefit from immunotherapy; MC1 patients were more sensitive to immune checkpoint inhibitors and traditional chemotherapy drugs. The multiclass AUCs based on the RNASeq and GSE cohorts were 0.93 and 0.84, respectively. Finally, we screened 11 potential gene markers related to the metabolic characteristic index that could be used to indicate the prognosis of OC. Conclusion. Molecular subtypes related to metabolism are crucial to comprehensively understand the molecular pathological characteristics related to metabolism for OC development, explore reliable markers for prognosis, improve the OC staging system, and guide personalized treatment.

学科与关键词

关键词
INDOLEAMINE 2,3-DIOXYGENASETUMOR MICROENVIRONMENTSIGNALING PATHWAYSEXPRESSIONMECHANISMSHALLMARKSSUBSETSMODELSIMPACT
相关
加载中…
  • Immune-and Metabolism-Associated Molecular Classi?cation of Ovarian Cancer
    Chen, Zhenyue; Jiang, Weiyi; Li, Zhen; Zong, Yun; Deng, Gaopi*Frontiers in Oncology, 2022, 12: 877369.被引 5
  • Tumor Immunometabolism Characterization in Ovarian Cancer With Prognostic and Therapeutic Implications
    Yang, Miner; Chen, Gaowen; Gao, Kunjie; Wang, Yifeng*Frontiers in Oncology, 2021, 11: 622752.被引 10
  • A random forest-based metabolic risk model to assess the prognosis and metabolism-related drug targets in ovarian cancer
    Zhang, Haoxin; Chi, Meng; Su, Dongqing; Xiong, Yuqiang; Wei, Haodong; Yu, Yao; Zuo, Yongchun*; Yang, Lei*Computers in Biology and Medicine, 2023, 153: 106432.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Immunology Research
发表日期
2022-06-25
卷期
第 2022 卷
页码
2359349
DOI
10.1155/2022/2359349
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
Postdoctoral Research Foundation of Heilongjiang Province [LBH-Q20145]; Science Foundation for Young Scholars of Heilongjiang Province [QC2018104]

作者

  • W

    Wang, Kexin (第一作者)

    1 · harbin med univ

  • H

    He, Hui

    1 · dalian med univ

查看全部 3 位作者收起作者
  • F

    Feng, Xue (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417